
|Videos|June 13, 2016
When to Choose Ticagrelor or Clopidogrel
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the scenarios in which certain patients may benefit from one acute coronary syndrome treatment regimen over another
Advertisement
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the scenarios in which certain patients may benefit from one acute coronary syndrome treatment regimen over another
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5














































































































































































































